Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pudilan oral liquid for acute upper respiratory tract infection
ChiCTR2200066258Phase 4Not yet recruiting
- Sponsor
- China-Japan Friendship Hospital
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Pudilan Xiaoyan in upper respiratory infection (URI) (2 arms), sponsored by China-Japan Friendship Hospital. Primary endpoint: Symptom resolution time. Planned start Jul 2022; status: not yet recruiting.
02
Drugs
Pudilan Xiaoyan
03
Conditions
upper respiratory infection (URI)
Beyond the preview
Go deeper on ChiCTR2200066258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066258.